Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) — Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) is a clinical research site located in Las Vegas, Nevada, United States 89109.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has participated in 3 clinical trials.

Therapeutic areas: Tumors With CDK4/6 Pathway Activation, Basal Cell Carcinoma, Tumor Pathway Activations Inhibited by Dovitinib.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Las Vegas

Browse all research sites in Nevada · View every site in Las Vegas

• University of Nevada at Las Vegas
• University Nevada - Las Vegas
• VA Southern Nevada Healthcare
• Sunrise Hospital
• University of Nevada Las Vegas
• Cure 4 The Kids Foundation, A Division of Roseman University of Health Sciences
• University of Nevada School of Medicine
• Sunrise Hospital/eStudySite
• Valley Hospital and Medical Center
• Sunrise Hospital & Medical Center
• MountianView Hospital
• University of Nevada, Las Vegas (UNLV) School of Medicine

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2)?

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) conducted?

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has 3 clinical trials on record. Their work covers Tumors With CDK4/6 Pathway Activation, Basal Cell Carcinoma, Tumor Pathway Activations Inhibited by Dovitinib.

Is Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) accredited by Crixeo Clinical Trials?

Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.